Ephedrine sulfate - Par Pharmaceutical

Drug Profile

Ephedrine sulfate - Par Pharmaceutical

Alternative Names: Corphedra

Latest Information Update: 07 Mar 2017

Price : $50

At a glance

  • Originator Par Pharmaceutical Inc
  • Class Antihypotensives; Decongestants; Propanolamines
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Beta-adrenergic receptor agonists; Central nervous system modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Hypotension

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 30 Jan 2017 Registered for Hypotension in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top